Miliary tuberculosis
ICD-10 A19 is a used to indicate a diagnosis of miliary tuberculosis.
Miliary tuberculosis is a disseminated form of tuberculosis (TB) characterized by the presence of numerous small lesions resembling millet seeds in the lungs and other organs. It occurs when Mycobacterium tuberculosis spreads through the bloodstream, leading to widespread infection. Patients may present with nonspecific symptoms such as fever, night sweats, weight loss, and fatigue. Diagnostic methods include chest X-rays, which may show diffuse nodular opacities, and sputum tests, although sputum may not always be positive due to the nature of the disease. Additional tests such as CT scans and biopsy of affected tissues can aid in diagnosis. Treatment typically involves a prolonged course of multiple antitubercular medications, including isoniazid, rifampicin, pyrazinamide, and ethambutol, for at least six months. Monitoring for drug resistance is critical, as miliary TB can be associated with multidrug-resistant strains. Public health implications are significant, necessitating contact tracing and isolation procedures to prevent transmission, especially in high-risk populations.
Detailed documentation of diagnostic tests, treatment plans, and follow-up care.
Patients presenting with systemic symptoms and confirmed TB exposure.
Consideration of drug resistance and public health implications in documentation.
Thorough pulmonary assessments, imaging results, and treatment response evaluations.
Patients with respiratory symptoms and abnormal imaging findings suggestive of miliary TB.
Documentation of lung function tests and any coexisting pulmonary conditions.
Used to evaluate suspected miliary TB.
Document the reason for the X-ray and findings.
Pulmonologists should ensure imaging correlates with clinical findings.
Common symptoms include fever, night sweats, weight loss, fatigue, and respiratory distress. Symptoms may vary based on the organs involved.
